Cancer

Drug resistance is one of the most persistent obstacles in modern cancer care, allowing malignant cells to survive treatments that...

Osteosarcoma, a rare but aggressive bone cancer that most often strikes children and adolescents, is at the center of a...

The Board of Governors of St. Jude Children’s Research Hospital has named Charles W.M. Roberts, MD, PhD, as the institution’s...

CAR T-cell therapy has changed the outlook for people with some of the most aggressive blood cancers, turning a patient’s...

Researchers at the Yong Loo Lin School of Medicine at the National University of Singapore have identified a molecular “master...

Rectal cancer is often described as a disease of malignant cells, but the biology surrounding those cells can be just...

A retraction notice in Experimental & Molecular Medicine has withdrawn a high-profile claim about how the cancer-linked NOTCH signaling pathway...

Metabolic and alcohol-associated liver disease, or MetALD, is emerging as one of the most consequential—and least recognized—forms of chronic liver...

HOUSTON, Aug. 17, 2026 — The University of Texas MD Anderson Cancer Center has announced its 2026 class of Andrew...

A stress-sensing pathway that helps natural killer cells mature and attack cancer may become a liability when activated continuously, according...